News of mega-mergers involving the likes of Pfizer and Wyeth or Merck and Schering Plough have turned the pharmaceutical industry on its ear. But what does this mean for you and your patients? John Kreger, a principal with the health care investment bank William Blair & Company, tells the Chicago Tribune's Bruce Japsen about how consolidation among drug companies could impact doctors and their patients.
ReachMD
Be part of the knowledge.™When Drug Companies Merge & the Effect on Your Practice
closeChoose a format
Media formats available:
Programs 5/10/21
Facebook Comments